60 Degrees Pharmaceuticals (SXTP) entered an exclusive option agreement with the Florida State University Research Foundation (FSURF) covering related intellectual property for its vector-borne disease treatment program. The deal suggests progress in securing/advancing its IP portfolio, though no financial terms or clinical milestones were provided in the excerpt.
60 Degrees Pharmaceuticals (SXTP) entered an exclusive option agreement with the Florida State University Research Foundation (FSURF) covering related intellectual property for its vector-borne disease treatment program. The deal suggests progress in securing/advancing its IP portfolio, though no financial terms or clinical milestones were provided in the excerpt.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
